Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Ixazomib or Lenalidomide Maintenance Following Autologous Stem Cell Transplantation and Ixazomib, Lenalidomide, and Dexamethasone (IRD) Consolidation in Patients with Newly Diagnosed Multiple Myeloma: Results from a Large Multi-Center Randomized Phase II Trial

Ravi Vij, MBBS, Thomas G. Martin, III, MD, Nitya Nathwani, MD, Mark A. Fiala, BS, Feng Gao, PhD, Abhinav Deol, MD, Francis K. Buadi, MB, CHB, Jonathan L. Kaufman, MD, Craig C Hofmeister, MDMPH, Tara K. Gregory, MD, Jesus G. Berdeja, MD, Ajai Chari, MD, Ashley E. Rosko, MD

Blood (2019) 134 (Supplement_1): 602.

https://doi.org/10.1182/blood-2019-130644

Published: 2019

Journal Articles

Baricitinib Prevents and Treats GvHD through Both Immune Modulation and Enhancement of Tissue Repair

Kidist Ashami, BA, Kiran R. Vij, MD, Julie Ritchey, Srikanth Santhanam, PhD, Karl W. Staser, MD PhD, Sora Lim, Sena Kim, Matthew L. Cooper, PhD, Feng Gao, PhD, Matthew Ciorba, John F. DiPersio, MD PhD, Jaebok Choi, PhD

Blood (2018) 132 (Supplement 1): 3311.

https://doi.org/10.1182/blood-2018-99-119470

Published: 2018

Journal Articles

HLA Class II Epitope Mismatch Influences Relapse and Engraftment in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

Joseph Rimando, MD, Michael Slade, MD MS, Feng Gao, PhD, Rizwan Romee, MD, Chang Liu, MD PhD

Blood (2018) 132 (Supplement 1): 4634.

https://doi.org/10.1182/blood-2018-99-112494

Published: 2018

Journal Articles

An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies

Blood (2017) 130 (Supplement 1): 844.

https://doi.org/10.1182/blood.V130.Suppl_1.844.844

Published: 2017

Journal Articles

The Relationship between HLA Disparity and Clinical Outcomes in Peripheral Blood T Cell Replete Haploidentical Hematopoietic Cell Transplantation

Joseph Rimando, BS, Michael Slade, MDMS, Feng Gao, PhD, Rizwan Romee, MD

Blood (2017) 130 (Supplement 1): 4555.

https://doi.org/10.1182/blood.V130.Suppl_1.4555.4555

Published: 2017

Journal Articles

Clinical Characteristics of Isolated CNS Relapse after Allogeneic Transplantation for AML — Poor Outcomes Despite Longer Time to Relapse

Pavan Kumar Bhamidipati, MBBS, MD, Armin Ghobadi, MD, Han Se-Young, MD, Shivaprasad Manjappa, MD, Feng Gao, PhD, Peter Westervelt, MDPhD, Geoffrey L. Uy, MD, Camille N. Abboud, MD, Mark A. Schroeder, MD, John F DiPersio, MD PhD

Blood (2017) 130 (Supplement 1): 4566.

https://doi.org/10.1182/blood.V130.Suppl_1.4566.4566

Published: 2017

Journal Articles

FLT3 Positivity Is a Predictor of Early Relapse Post-Transplantation — Allo-HCT Is an Ineffective Salvage Strategy in Active AML

Pavan Kumar Bhamidipati, MBBS, MD, Han Se-Young, MD, Shivaprasad Manjappa, MD, Feng Gao, PhD, Mark A. Schroeder, MD, Ravi Vij, MDMBA, Amanda F. Cashen, MD, Camille N. Abboud, MD, John F DiPersio, MD PhD

Blood (2017) 130 (Supplement 1): 4567.

https://doi.org/10.1182/blood.V130.Suppl_1.4567.4567

Published: 2017

Journal Articles

Prognostic Significance of Minimal Residual Disease in Patients with Secondary Acute Myeloid Leukemia

Chi-Joan How, MD, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Feng Gao, PhD, Rizwan Romee, MD

Blood (2017) 130 (Supplement 1): 5085.

https://doi.org/10.1182/blood.V130.Suppl_1.5085.5085

Published: 2017

Journal Articles

Addition of Mycophenolate Mofetil to Methotrexate and Tacrolimus Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

Se young Han, MD, Pavan Kumar Bhamidipati, MBBS,MD, Khoan Vu, MD, John F Dipersio, MD PhD, Feng Gao, PhD, Iskra Pusic, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Ravi Vij, MD, Mark A. Schroeder, MD, Camille N. Abboud, MD FACP, Keith Stockerl-Goldstein, MD, Amanda F. Cashen, MD, Todd A Fehniger, MD PhD, Rizwan Romee, MD

Blood (2015) 126 (23): 3144.

https://doi.org/10.1182/blood.V126.23.3144.3144

Published: 2015

Journal Articles

Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

Brian T Hess, MD, Feng Gao, PhD, John F. DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD FACP, Mark A. Schroeder, MD, Iskra Pusic, MD, Armin Ghobadi, MD, Amanda F. Cashen, MD, Todd A Fehniger, MD PhD, Meagan A. Jacoby, MD PhD, Rizwan Romee, MD

Blood (2015) 126 (23): 1950.

https://doi.org/10.1182/blood.V126.23.1950.1950

Published: 2015

Journal Articles

CD34 + -Selected Infusions of Fresh or Cryopreserved Peripheral Blood Stem Cells for the Treatment of Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplant

Armin Ghobadi, MD, Mark A Fiala, BS, CCRP, Giridharan Ramsingh, MD, Feng Gao, PhD, Camille N. Abboud, MD, Keith Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, John F. DiPersio, MD PhD

Blood (2015) 126 (23): 3098.

https://doi.org/10.1182/blood.V126.23.3098.3098

Published: 2015

Journal Articles

Acute Myeloid Leukemia Patients with Pre-Transplant Ablated Marrows Have Similar Rates of Survival and Relapse Compared to Patients in Complete Remission after Allogeneic Hematopoietic Cell Transplantation

Khoan Vu, MD, Shivaprasad Manjappa, MD, John F. DiPersio, MD PhD, Feng Gao, PhD, Peter Westervelt, MD PhD, Ravi Vij, MBBS, MD, Keith E. Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Camille N. Abboud, MD, Mark A. Schroeder, MD, Amanda F. Cashen, MD, Rizwan Romee, MD

Blood (2014) 124 (21): 2557.

https://doi.org/10.1182/blood.V124.21.2557.2557

Published: 2014

Journal Articles

Haploidentical Peripheral Blood Stem Cell Transplantation Using Non-Myeloablative Conditioning With Post-Transplant Cyclophosphamide Regimen Is Safe and Is Associated With Very Encouraging Post-Transplant Outcomes

Pavan Kumar Bhamidipati, MD, John F. DiPersio, MD, PhD, Keith Stokerl-Goldstein, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD, PhD, Feng Gao, PhD, Ravi Vij, MD, Mark A. Schroeder, MD, Camille N. Abboud, MD, Iskra Pusic, MD, Shivaprasad Manjappa, MD, Rizwan Romee, MD

Blood (2013) 122 (21): 4532.

https://doi.org/10.1182/blood.V122.21.4532.4532

Published: 2013

Journal Articles

Predicting Autologous Stem Cell Mobilization Failure In Hematologic Malignancies

Pavan Bhamidipati, MD, Mark A. Fiala, BS, CCRP, Stephanie Wang, Trisha Sturgill, Feng Gao, PhD, Camille N. Abboud, MD, Amanda F Cashen, MD, Meagan Jacoby, MD, Iskra Pusic, MD, Rizwan Romee, MD, Mark A. Schroeder, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Keith E. Stockerl-Goldstein, MD

Blood (2013) 122 (21): 2034.

https://doi.org/10.1182/blood.V122.21.2034.2034

Published: 2013

Journal Articles

A Phase I Dose-Escalation Study of Combination Decitabine, Arsenic Trioxide and Ascorbic Acid In Patients with MDS and AML

John S. Welch, MD, PhD, Jeffery Klco, MD, Feng Gao, PhD, Anjum Hassan, MD, Ravi Vij, MBBS, MD

Blood (2010) 116 (21): 2148.

https://doi.org/10.1182/blood.V116.21.2148.2148

Published: 2010

Journal Articles

Phase I Study of Intravenous Plerixafor Added to a Mobilization Regimen of G-CSF In Lymphoma Patients Undergoing Autologous Stem Cell Collection

Amanda Cashen, MD, Michael P. Rettig, PhD, Feng Gao, PhD, Camille N. Abboud, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD

Blood (2010) 116 (21): 823.

https://doi.org/10.1182/blood.V116.21.823.823

Published: 2010

Journal Articles

Azacitidine-Induced Changes in the MDS Methylome Are Associated with Clinical Responses

Michael G. Martin, MD, Richard Walgren, MD, PhD, Elizabeth Procknow, Peter Westervelt, MD, PhD, Camille N Abboud, MD, Amanda F Cashen, MD, Keith Stockerl-Goldstein, MD, Feng Gao, PhD, John F DiPersio, MD, PhD, Ravi Vij, MD

Blood (2008) 112 (11): 2691.

https://doi.org/10.1182/blood.V112.11.2691.2691

Published: 2008

NARROW

Ixazomib or Lenalidomide Maintenance Following Autologous Stem Cell Transplantation and Ixazomib, Lenalidomide, and Dexamethasone (IRD) Consolidation in Patients with Newly Diagnosed Multiple Myeloma: Results from a Large Multi-Center Randomized Phase II Trial

Baricitinib Prevents and Treats GvHD through Both Immune Modulation and Enhancement of Tissue Repair

HLA Class II Epitope Mismatch Influences Relapse and Engraftment in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies

The Relationship between HLA Disparity and Clinical Outcomes in Peripheral Blood T Cell Replete Haploidentical Hematopoietic Cell Transplantation

Clinical Characteristics of Isolated CNS Relapse after Allogeneic Transplantation for AML — Poor Outcomes Despite Longer Time to Relapse

FLT3 Positivity Is a Predictor of Early Relapse Post-Transplantation — Allo-HCT Is an Ineffective Salvage Strategy in Active AML

Prognostic Significance of Minimal Residual Disease in Patients with Secondary Acute Myeloid Leukemia

Addition of Mycophenolate Mofetil to Methotrexate and Tacrolimus Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

CD34 + -Selected Infusions of Fresh or Cryopreserved Peripheral Blood Stem Cells for the Treatment of Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplant

Acute Myeloid Leukemia Patients with Pre-Transplant Ablated Marrows Have Similar Rates of Survival and Relapse Compared to Patients in Complete Remission after Allogeneic Hematopoietic Cell Transplantation

Haploidentical Peripheral Blood Stem Cell Transplantation Using Non-Myeloablative Conditioning With Post-Transplant Cyclophosphamide Regimen Is Safe and Is Associated With Very Encouraging Post-Transplant Outcomes

Predicting Autologous Stem Cell Mobilization Failure In Hematologic Malignancies

A Phase I Dose-Escalation Study of Combination Decitabine, Arsenic Trioxide and Ascorbic Acid In Patients with MDS and AML

Phase I Study of Intravenous Plerixafor Added to a Mobilization Regimen of G-CSF In Lymphoma Patients Undergoing Autologous Stem Cell Collection

Azacitidine-Induced Changes in the MDS Methylome Are Associated with Clinical Responses

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only